Flavia Galli
A5101521900- Nosocomial Infections in ICU
- Pneumonia and Respiratory Infections
- Sepsis Diagnosis and Treatment
- COVID-19 Clinical Research Studies
- Respiratory Support and Mechanisms
- Bacterial biofilms and quorum sensing
- Antimicrobial Peptides and Activities
- Thyroid Cancer Diagnosis and Treatment
- Healthcare cost, quality, practices
- Corneal Surgery and Treatments
- Corneal surgery and disorders
- Intensive Care Unit Cognitive Disorders
- Inhalation and Respiratory Drug Delivery
- Long-Term Effects of COVID-19
- Dermatologic Treatments and Research
- COVID-19 Impact on Reproduction
Consorci Institut D'Investigacions Biomediques August Pi I Sunyer
2024-2025
Universitat de Barcelona
2024-2025
Istituti di Ricovero e Cura a Carattere Scientifico
2023
Università Cattolica del Sacro Cuore
2023
University of Milan
2007
Although the prevalence of community-acquired respiratory bacterial coinfection upon hospital admission in patients with coronavirus disease 2019 (COVID-19) has been reported to be < 5%, almost three-quarters received antibiotics. We aim investigate whether procalcitonin (PCT) or C-reactive protein (CRP) could helpful biomarkers identify among COVID-19 pneumonia. carried out a multicentre, observational cohort study including consecutive admitted 55 Spanish intensive care units (ICUs). The...
The management of severe SARS-CoV-2 pneumonia, alongside logistical constraints, evolved between the first and subsequent COVID-19 waves. This study aimed to compare prevalence early bacterial pulmonary co-infections incidence ventilator-associated lower respiratory tract infections (VA-LRTI) across second waves pandemic, characterize their microbiology. Latter part a multicenter retrospective European cohort analysis conducted in 35 ICUs. Adult patients admitted for pneumonia requiring...
<b>Background:</b> The frequency of community acquired respiratory bacterial coinfection upon hospital admission in COVID-19 patients has been reported to be <4%, but almost three-quarters received antibiotics. <b>Aim:</b> To investigate whether procalcitonin(PCT) could used identify with pneumonia. <b>Methods:</b> Multicenter, observational cohort study including consecutive admitted 55 Spanish ICUs. Primary outcome was explore PCT levels predict coinfection. Secondary evaluate the...
<b>Introduction:</b> We recently demonstrated the potential of engineered live bacteria against <i>Pseudomonas</i><i>aeruginosa</i><i>ex vivo</i> biofilms grown in endotracheal tubes (ETT) from patients with ventilator-associated pneumonia (VAP)<sup>1,2</sup> (Fig.1A). <b>Aim:</b> To test vivo efficacy genetically modified <i>Mycoplasma</i><i>pneumoniae</i> strain (CV8_HA_P1) <i>P. aeruginosa</i> ETT-biofilms mechanically ventilated pigs VAP. <b>Methods:</b> Fourteen previously infected...
<b>Background:</b> Immunosuppressed patients could be considered at increased risk of severe COVID-19 pneumonia although, to date, few studies describe their clinical course in ICU setting,1,2 mostly small sample sizes. The aim this study was features and outcomes comparison with not immunosuppressed patients. <b>Materials methods:</b> Multicenter, observational case-control including admitted 55 Spanish ICUs (NCT04457505). Main characteristics, complications were analyzed <b>Results:</b>...